Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy
Micro and Nano Technologies Series

Authors:

Language: English
Cover of the book Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy

Subject for Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy

177.10 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Publication date:
310 p. · 19x23.3 cm · Paperback

Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy reviews the principles and applications of nanocarriers for targeted drug delivery. Drug targeting involves active and passive strategies that exploit both the use of ligands for interactions and the physical and chemical properties of nanocarriers and micro-environments at target sites. Multidrug resistance and adverse side effects associated with anticancer drugs have attracted greater scientific attention and led formulation scientists to specifically target these drugs to target sites. Nanocarriers like liposomes, niosomes, gold nanorods, carbon nanotubes, and micelles are discussed for the delivery of drugs to specific disease sites.

This is an important reference source for researchers in the biomedical and biomaterials fields who want to gain an understanding on how nanotechnology is used for earlier diagnoses and more effective cancer treatment.

1. Potential physical and biological barriers leading to failure of cancer chemotherapy2. Nanotechnological strategies involved in the targeted delivery of anti-cancer drugs3. Liposome based targeted delivery of anticancer drugs and effective therapy of tumors4. Organic ligands as nanocarrier for targeted delivery of mediated active drug targeting for liver cancer5. Surface functionalized magnetic nanoparticles in cancer drugs delivery and diagnosis6. Nano-carriers based targeted pulmonary delivery: Novel approaches for effective lung cancer treatment7. Enhancing therapeutic efficacy of anticancer drugs through functionalized niosomes targeting8. Carbon nanotubes: Versatile nanocarriers for effective delivery of anti-cancer drugs9. Construction of stimulus responsive micelles systems for efficient targeting of cancer drugs10. Nano-targeted radiopharmaceuticals for cancer diagnosis and treatment11. Potential role of gold nanoparticles in cancer diagnosis and targeted drug delivery
materials scientists, biomedical scientists, bioengineers, and pharmaceutical scientists
Muhammad Raza Shah is a full professor at the International Center for Chemical and Biological Sciences, HEJ Research Institute of Chemistry, University of Karachi, Pakistan. He is also the Head of the Center for Bioequivalence Studies and Clinical Research. He is a recipient of several awards, including the Tamgha-i-Imtiaz Award from the President of Pakistan, the Salam Prize, the Professor Atta ur Rahman Gold Medal, and the Dr M Raziuddin Siddiqi Prize, by the Pakistan Academy of Sciences, for scientists under 40 years of age, in the field of chemistry. Professor Shah has authored six books and edited four books, in addition to contributing over 350 peer-reviewed journal papers. One of his authored books was declared as best book of 2017 by the Government of Pakistan’s Higher Education Commission.
Muhammad Imran is a graduate student and based at the International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University of Karachi, Pakistan.
Shafi Ullah is a graduate student and based at the International Center for Chemical and Biological Sciences, H.E.J. Research Institute of Chemistry University of Karachi, Pakistan.
  • Explores the fundamental principles of drug targeting through different nano-carriers, highlighting major applications
  • Shows how the use of nanocarriers is leading to quicker cancer diagnosis and more effective treatment
  • Discusses the major challenges of using nanocarriers for drug delivery and assesses how to overcome these barriers